Stockreport

Neumora Therapeutics Inc (NMRA) Q4 2025 Earnings Call Highlights: Strong Financial Position ... [Yahoo! Finance]

Neumora Therapeutics, Inc.  (NMRA) 
PDF Cash Runway: Expected to support operations into the third quarter of 2027. Net Loss: Total net loss for 2025 was comparable to the same period in 2024. Release Dat [Read more]